Evidence map›Paper›PMID 25902484›Full record

ArticleImmunity2015

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.

Xiaohuan Guo, Yong Liang, Yuan Zhang, Anna Lasorella, Barbara L Kee, Yang-Xin Fu

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. RORγtNature communications · 2026
    Article
  6. tRNA mCell discovery · 2026
    Article
  7. Review
  8. Article
  9. Gut microbiota shapes cancer immunotherapy responses.NPJ biofilms and microbiomes · 2025
    Review
  10. The sweet side of IL-22.Nature microbiology · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Xiaohuan GuoDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA; Tsinghua University School of Medicine, Beijing 100084, China. Electronic address: guoxiaohuan@biomed.tsinghua.edu.cn.
Yong LiangDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA; Institute of Biophysics and The University of Chicago joint Group for Immunotherapy, Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China.
Yuan ZhangDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA.
Anna LasorellaInstitute for Cancer Genetics, Departments of Neurology and Pathology, Columbia University Medical Center, New York, NY 10032, USA.
Barbara L KeeDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA.
Yang-Xin FuDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637, USA; Institute of Biophysics and The University of Chicago joint Group for Immunotherapy, Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China. Electronic address: yfu@uchicago.edu.
University of Chicago · USChinese Academy of Sciences · CNColumbia University Irving Medical Center · USInstitute of Biophysics · CN

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Transcriptional Control of Natural Killer Cell DevelopmentR01AI106352 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2014 to 2023
$4.6M
Novel therapeutic approaches to treating chronic hepatitis B virus infectionR01DK095962 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FU, YANG-XIN, SU, LISHAN · 2013 to 2016
$2.1M
Tumor Necrosis Superfamily Ligands and Lymphocytes Role in Liver RegenerationR01DK080736 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ANDERS, ROBERT A. · 2010 to 2014
$1.7M
The role of Id2 in gut innate lymphoid cellsR01DK100427 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI FU, YANG-XIN · 2014 to 2017
$1.4M
NCATS NIH HHS UL1 TR000430NIAID NIH HHS AI106352NIAID NIH HHS R01 AI106352NIDDK NIH HHS DK080736NIDDK NIH HHS DK095962NIDDK NIH HHS DK100427NIDDK NIH HHS R01 DK080736NIDDK NIH HHS R01 DK095962NIDDK NIH HHS R01 DK100427
6 · The paper itself

Abstract

Microbiota-mediated effects on the host immune response facilitate colonization resistance against pathogens. However, it is unclear whether and how the host immune response can regulate the microbiota to mediate colonization resistance. ID2, an essential transcriptional regulator for the development of innate lymphoid cell (ILC) progenitors, remains highly expressed in differentiated ILCs with unknown function. Using conditionally deficient mice in which ID2 is deleted from differentiated ILC3s, we observed that these mutant mice exhibited greatly impaired gut colonization resistance against Citrobacter rodentium. Utilizing gnotobiotic hosts, we showed that the ID2-dependent early colonization resistance was mediated by interleukin-22 (IL-22) regulation of the microbiota. In addition to regulating development, ID2 maintained homeostasis of ILC3s and controlled IL-22 production through an aryl hydrocarbon receptor (AhR) and IL-23 receptor pathway. Thus, ILC3s can mediate immune surveillance, which constantly maintains a proper microbiota, to facilitate early colonization resistance through an ID2-dependent regulation of IL-22.

Indexed as

AnimalsCell DifferentiationCitrobacter rodentiumEnterobacteriaceae InfectionsGene Expression RegulationGerm-Free LifeHomeostasisImmunity, InnateInhibitor of Differentiation Protein 2Interleukin-22InterleukinsLymphocytesMiceMice, Inbred C57BLMice, KnockoutMicrobiotaIdb2 protein, mouseInhibitor of Differentiation Protein 2Interleukin-22interleukin-23 receptor, mouseInterleukinsReceptors, Aryl HydrocarbonReceptors, Interleukin

Identifiers

PMID25902484
PMCPMC4725053
OpenAlexW2041747019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.